Versant Venture Management as of Sept. 30, 2016
Portfolio Holdings for Versant Venture Management
Versant Venture Management holds 7 positions in its portfolio as reported in the September 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Audentes Therapeutics | 35.9 | $32M | 1.8M | 17.81 | |
| Immune Design | 18.7 | $17M | 2.2M | 7.58 | |
| Ocular Therapeutix (OCUL) | 17.0 | $15M | 2.2M | 6.87 | |
| Clovis Oncology | 16.4 | $15M | 407k | 36.05 | |
| Achaogen | 6.8 | $6.1M | 1.3M | 4.79 | |
| Glaukos (GKOS) | 3.0 | $2.7M | 71k | 37.74 | |
| Cymabay Therapeutics | 2.3 | $2.0M | 1.0M | 1.94 |
